A Survey on Psychosomatic Health Status of Chinese Population

December 15, 2023 updated by: Yonggui Yuan
A Survey on Psychosomatic Health Status of Chinese Population

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

This is a nationwide cross-sectional study to investigate psychosomatic symptoms among genral population in China. This study will also focus on the relationship between psychosomatic symptoms and functions and wellbeing.

Study Type

Observational

Enrollment (Estimated)

300000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

General population in China

Description

Inclusion Criteria:

  • Age 18 years old and above;
  • Able to complete the scale independently;
  • Subjects read informed consent through online questionnaires and agreed to cooperate with relevant assessments.

Exclusion Criteria:

  • Individuals with severe physical disease;
  • Individuals with cognitive impairment;
  • Individuals who cannot finish the online survay independently.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
General Pupulation of China

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychosomatic health status
Time Frame: Baseline
symptoms severity measured by the symptoms checklist of this study
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yonggui Yuan

Investigators

  • Study Chair: Yonggui Yuan, Prof., Zhongda Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 17, 2023

Primary Completion (Estimated)

January 31, 2024

Study Completion (Estimated)

January 31, 2024

Study Registration Dates

First Submitted

December 1, 2023

First Submitted That Met QC Criteria

December 1, 2023

First Posted (Actual)

December 11, 2023

Study Record Updates

Last Update Posted (Actual)

December 22, 2023

Last Update Submitted That Met QC Criteria

December 15, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • CN_Psychosomatic_20231201

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Well-Being, Psychological

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe